Vimarsana
Biggest News Aggregation in the World

Allarity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allarity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allarity Today - Breaking & Trending Today

Allarity Therapeutics, Inc.: This Combination Therapy Could Help Change Cancer Treatment - Take A Deeper Look Into Allarity Therapeutics' Trial - Vimarsana News

Allarity Therapeutics, Inc.: This Combination Therapy Could Help Change Cancer Treatment - Take A Deeper Look Into Allarity Therapeutics' Trial

CAMBRIDGE, MA / ACCESSWIRE / April 17, 2023 / Allarity Therapeutics (NASDAQ:ALLR) dosed its first patient in Phase 1b of its clinical trial for the novel combination therapy of two drugs, stenoparib and

Allarity Therapeutics, Inc.: Allarity Therapeutics Announces Reverse Stock Split of Common Stock - Vimarsana News

Allarity Therapeutics, Inc.: Allarity Therapeutics Announces Reverse Stock Split of Common Stock

Common Stock Will Begin Trading on a Post-Split Adjusted Basis on March 27, 2023 Press releaseBOSTON, Mass - March 24, 2023 - Allarity Therapeutics, Inc. (Nasdaq: ALLR) ("Allarity" or the "Company"), a

EQS-News: Precision Medicine Could Get Even More Precise With Allarity Therapeutics' "Next-Generation" Diagnostics Platform - Vimarsana News

EQS-News: Precision Medicine Could Get Even More Precise With Allarity Therapeutics' "Next-Generation" Diagnostics Platform

EQS-News: Allarity Therapeutics, Inc. Precision Medicine Could Get Even More Precise With Allarity Therapeutics’ “Next-Generation” Diagnostics Platform 18.10.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Once brought into its pipeline, Allarity uses...

Allarity Therapeutics Announces Appointment of New Auditor - Vimarsana News

Allarity Therapeutics Announces Appointment of New Auditor

Press release     Cambridge, MA U.S.A. — Allarity Therapeutics, Inc. , a clinical-stage pharmaceutical company developing novel oncology therapeutics together with... | September 12, 2022

Allarity Therapeutics : Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) - Form 8-K - Vimarsana News

Allarity Therapeutics : Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) - Form 8-K

Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250 Cambridge, MA U.S.A. - Allarity Therapeutics, Inc. , a clinical-stage... | April 22, 2022